PMV Pharmaceuticals Inc (PMVP): Next-Year EPS Estimate 25.71%
As of 2026-05-12, PMV Pharmaceuticals Inc (PMVP) has a next-year EPS growth estimate of 25.71%.
On 2026-05-12, analyst consensus for PMVP's next-year EPS growth shifted from 26.11% to 25.71% — a negative change of 0.40 percentage points. Current-year growth is projected at -2.48%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 25.71%
- EPS growth this year
- -2.48%
- EPS next quarter (est)
- -$0.41
- Last price
- $1.43
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-12 | 25.71% | -2.48% | -$0.41 | $1.43 |
| 2026-05-11 | 26.11% | -6.08% | -$0.41 | $1.39 |
| 2026-05-10 | 26.11% | -6.08% | -$0.41 | $1.41 |
| 2026-05-07 | 26.11% | -6.08% | -$0.41 | $1.42 |
| 2026-05-06 | 26.11% | -6.08% | -$0.41 | $1.45 |
| 2026-05-05 | 26.11% | -6.08% | -$0.41 | $1.37 |
| 2026-05-04 | 26.11% | -6.08% | -$0.41 | $1.40 |
| 2026-05-03 | 26.11% | -6.08% | -$0.41 | $1.39 |
| 2026-04-30 | 26.11% | -6.08% | -$0.41 | $1.39 |
| 2026-04-29 | 26.11% | -6.08% | -$0.41 | $1.39 |
| 2026-04-28 | 26.11% | -6.08% | -$0.41 | $1.42 |
| 2026-04-27 | 26.11% | -6.08% | -$0.41 | $1.44 |
| 2026-04-26 | 26.11% | -6.08% | -$0.41 | $1.44 |
| 2026-04-24 | 26.11% | -6.08% | -$0.41 | $1.44 |
| 2026-04-23 | 26.11% | -6.08% | -$0.41 | $1.43 |
| 2026-04-22 | 26.11% | -6.08% | -$0.41 | $1.48 |
| 2026-04-21 | 26.11% | -6.08% | -$0.41 | $1.46 |
| 2026-04-20 | 26.11% | -6.08% | -$0.41 | $1.43 |
| 2026-04-19 | 26.11% | -6.08% | -$0.41 | $1.38 |
| 2026-04-16 | 26.11% | -6.08% | -$0.41 | $1.37 |
| 2026-04-15 | 26.11% | -6.08% | -$0.41 | $1.41 |
| 2026-04-14 | 26.11% | -6.08% | -$0.41 | $1.47 |
| 2026-04-13 | 26.11% | -6.08% | -$0.41 | $1.35 |
| 2026-04-12 | 26.11% | -6.08% | -$0.41 | $1.32 |
| 2026-04-10 | 26.11% | -6.08% | -$0.41 | $1.30 |
| 2026-04-09 | 26.11% | -6.08% | -$0.41 | $1.33 |
| 2026-04-08 | 26.11% | N/A | -$0.41 | $1.25 |
| 2026-04-07 | 26.11% | N/A | -$0.41 | $1.29 |
| 2026-04-06 | 26.11% | N/A | -$0.41 | $1.29 |
| 2026-04-05 | 26.11% | N/A | -$0.41 | $1.34 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is PMV Pharmaceuticals Inc's next-year EPS growth estimate?▾
As of 2026-05-12, PMV Pharmaceuticals Inc (PMVP) has a next-year EPS growth estimate of 25.71%, based on analyst consensus.
When was the latest EPS estimate revision for PMVP?▾
The most recent revision occurred on 2026-05-12, when analysts adjusted the next-year EPS growth estimate from 26.11% to 25.71%.
What sector and industry does PMV Pharmaceuticals Inc belong to?▾
PMV Pharmaceuticals Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. PMVP appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. PMV Pharmaceuticals Inc (PMVP) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports